Halozyme Therapeutics (HALO) Interest Coverage Ratio: History & Chart

Halozyme Therapeutics, Inc.(HALO)

Biotechnology · San Diego, CA

$110.02+1.71 (+1.58%)

Delayed quote: Oct 6, 2026, 11:45 AM EDT

About Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. is a biopharmaceutical company headquartered in San Diego, California, with operations spanning the United States, Switzerland, Ireland, Belgium, Japan, and other international markets. At its core is the proprietary ENHANZE drug delivery platform, which utilizes a patented recombinant human hyaluronidase enzyme (rHuPH20). This innovative technology significantly enhances the subcutaneous (under-the-skin) administration of a diverse range of injectable medicines. This includes complex biologics such as monoclonal antibodies, various other therapeutic molecules, smaller drug compounds, and even fluids. The company's leading product, Hylenex recombinant, is an rHuPH20 formulation specifically designed to facilitate subcutaneous fluid delivery for hydration. It also plays a crucial role in improving the dispersion and absorption of other injected drugs during subcutaneous urography, and aids in the resorption of radiopaque agents. Halozyme also offers several key therapeutics leveraging its platform, including Perjeta, RITUXAN HYCELA, and MabThera SC, which are used to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL). RITUXAN SC is another offering for CLL patients, while HYQVIA addresses various immunodeficiency disorders. Their development pipeline boasts numerous investigational drugs, such as Tecentriq for non-small cell lung cancer, OCREVUS for multiple sclerosis, and DARZALEX, which targets amyloidosis, smoldering myeloma, and multiple myeloma. Other pipeline candidates include nivolumab for solid tumors, ARGX-113 (a human neonatal Fc receptor), ARGX-117 for autoimmune diseases, and BMS-986179, an anti-CD-73 antibody. Halozyme maintains extensive collaborations with prominent pharmaceutical companies like F. Hoffmann-La Roche, Pfizer Inc., Janssen Biotech, Inc., AbbVie, Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Alexion Pharma Holding, ARGENX BVBA, and Horizon Therapeutics plc. They also partner with research institutions such as the National Institute of Allergy and Infectious Diseases, the Centre for the AIDS Programme of Research in South Africa, and ViiV Healthcare Limited, particularly focusing on both small and large molecule targets for the treatment and prevention of HIV. The company was established in 1998.

San Diego, CA

423 employees

www.halozyme.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Helen I. Torley

View full financials

HALO Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

45.03x

INTEREST COVERAGE RATIO AVG TTM

46.72x

INTEREST COVERAGE RATIO AVG 3Y

34.36x

INTEREST COVERAGE RATIO AVG 5Y

31.60x

INTEREST COVERAGE RATIO AVG 10Y

16.61x

INTEREST COVERAGE RATIO AVG 15Y

N/A

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-3.61%

CURRENT VS 3Y AVG

+31.06%

CURRENT VS 5Y AVG

+42.50%

CURRENT VS 10Y AVG

+171.08%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-5.63x

median of 442 covered companies

CURRENT VS SECTOR MEDIAN

+899.11%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Halozyme Therapeutics, Inc. (HALO)	$13.05B	45.03x	46.72x	34.36x	31.60x
Corcept Therapeutics Incorporated (CORT)vs ›	$12.92B	N/A	541.83x	541.83x	541.83x
Tempus AI, Inc. (TEM)vs ›	$13.20B	-3.60x	N/A	N/A	N/A
BridgeBio Pharma, Inc. (BBIO)vs ›	$13.25B	-10.72x	N/A	N/A	N/A
ICON Public Limited Company (ICLR)vs ›	$12.56B	5.38x	5.00x	4.08x	8.08x
Baxter International Inc. (BAX)vs ›	$12.53B	-1.06x	0.71x	2.65x	6.89x
Penumbra, Inc. (PEN)vs ›	$12.51B	144.35x	102.58x	62.73x	62.73x
BrightSpring Health Services, Inc. Common Stock (BTSG)vs ›	$12.51B	1.88x	1.39x	1.01x	1.11x
Encompass Health Corporation (EHC)vs ›	$12.37B	8.55x	7.42x	7.61x	6.89x
Ascendis Pharma A/S (ASND)vs ›	$14.24B	-1.69x	367.76x	367.76x	367.76x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Halozyme Therapeutics, Inc. (HALO)

$13.05B

45.03x

46.72x

34.36x

31.60x

Corcept Therapeutics Incorporated (CORT)vs ›

$12.92B

N/A

541.83x

Tempus AI, Inc. (TEM)vs ›

$13.20B

-3.60x

N/A

BridgeBio Pharma, Inc. (BBIO)vs ›

$13.25B

-10.72x

N/A

ICON Public Limited Company (ICLR)vs ›

$12.56B

5.38x

5.00x

4.08x

8.08x

Baxter International Inc. (BAX)vs ›

$12.53B

-1.06x

0.71x

2.65x

6.89x

Penumbra, Inc. (PEN)vs ›

$12.51B

144.35x

102.58x

62.73x

BrightSpring Health Services, Inc. Common Stock (BTSG)vs ›

$12.51B

1.88x

1.39x

1.01x

1.11x

Encompass Health Corporation (EHC)vs ›

$12.37B

8.55x

7.42x

7.61x

6.89x

Ascendis Pharma A/S (ASND)vs ›

$14.24B

-1.69x

367.76x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Halozyme Therapeutics, Inc. (HALO)?

The interest coverage ratio for HALO stock is 45.03x.

Is Halozyme Therapeutics, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 45.03x is 42% above its 5-year average of 31.60x, near the high end of its 5-year range (10.97x–53.11x).

What is the TTM average interest coverage ratio for Halozyme Therapeutics, Inc. (HALO)?

The TTM average interest coverage ratio for HALO stock is 46.72x.

What is the 3Y average interest coverage ratio for Halozyme Therapeutics, Inc. (HALO)?

The 3Y average interest coverage ratio for HALO stock is 34.36x.

What is the 5Y average interest coverage ratio for Halozyme Therapeutics, Inc. (HALO)?

The 5Y average interest coverage ratio for HALO stock is 31.60x.

What is the 10Y average interest coverage ratio for Halozyme Therapeutics, Inc. (HALO)?

The 10Y average interest coverage ratio for HALO stock is 16.61x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	51.48x
2026-03-31	33.50x
2025-12-31	51.80x
2025-09-30	50.73x
2025-06-30	46.07x
2025-03-31	31.28x
2024-12-31	38.66x
2024-09-30	36.07x
2024-06-30	25.91x
2024-03-31	21.20x
2023-12-31	19.36x
2023-09-30	19.60x
2023-06-30	21.02x
2023-03-31	11.84x
2022-12-31	16.30x
2022-09-30	11.08x
2022-06-30	10.97x
2022-03-31	43.02x
2021-12-31	27.51x
2021-09-30	43.09x
2021-06-30	53.11x
2021-03-31	25.82x
2020-12-31	15.41x
2020-09-30	8.08x
2020-06-30	5.91x
2020-03-31	-0.60x
2019-12-31	-8.59x
2019-09-30	-11.81x
2019-06-30	-5.35x
2019-03-31	0.93x
2018-12-31	-0.02x
2018-09-30	-5.94x
2018-06-30	-4.21x
2018-03-31	-4.53x
2017-12-31	23.07x
2017-09-30	1.46x
2017-06-30	-4.60x
2017-03-31	-5.05x
2016-12-31	-4.03x
2016-09-30	-4.33x
2016-06-30	-4.14x
2016-03-31	-4.17x
2015-12-31	4.20x
2015-09-30	-17.86x
2015-06-30	3.26x
2015-03-31	-10.71x
2014-12-31	-2.79x
2014-09-30	-13.83x
2014-06-30	-10.30x
2014-03-31	-18.33x
2013-12-31	-29.31x
2013-09-30	-21.76x
2013-06-30	-26.06x
2013-03-31	-21.82x

DATE

INTEREST COVERAGE RATIO

2026-06-30

51.48x

2026-03-31

33.50x

2025-12-31

51.80x

2025-09-30

50.73x

2025-06-30

46.07x

2025-03-31

31.28x

2024-12-31

38.66x

2024-09-30

36.07x

2024-06-30

25.91x

2024-03-31

21.20x

2023-12-31

19.36x

2023-09-30

19.60x

2023-06-30

21.02x

2023-03-31

11.84x

2022-12-31

16.30x

2022-09-30

11.08x

2022-06-30

10.97x

2022-03-31

43.02x

2021-12-31

27.51x

2021-09-30

43.09x

2021-06-30

53.11x

2021-03-31

25.82x

2020-12-31

15.41x

2020-09-30

8.08x

2020-06-30

5.91x

2020-03-31

-0.60x

2019-12-31

-8.59x

2019-09-30

-11.81x

2019-06-30

-5.35x

2019-03-31

0.93x

2018-12-31

-0.02x

2018-09-30

-5.94x

2018-06-30

-4.21x

2018-03-31

-4.53x

2017-12-31

23.07x

2017-09-30

1.46x

2017-06-30

-4.60x

2017-03-31

-5.05x

2016-12-31

-4.03x

2016-09-30

-4.33x

2016-06-30

-4.14x

2016-03-31

-4.17x

2015-12-31

4.20x

2015-09-30

-17.86x

2015-06-30

3.26x

2015-03-31

-10.71x

2014-12-31

-2.79x

2014-09-30

-13.83x

2014-06-30

-10.30x

2014-03-31

-18.33x

2013-12-31

-29.31x

2013-09-30

-21.76x

2013-06-30

-26.06x

2013-03-31

-21.82x

Interest Coverage Ratio: 45.03x

HALO Interest Coverage Ratio

HALO Average Interest Coverage Ratio Chart

HALO Current vs Average Interest Coverage Ratio Chart

HALO Interest Coverage Ratio Metrics

HALO Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

HALO Interest Coverage Ratio History

Related Metrics